Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Sigurdson

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Analytical Biochemistry|May 30, 2013
Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kineticsKwasi G Mawuenyega, Tom Kasten, Wendy Sigurdson, et al.
Science (New York, N.Y.)|December 15, 2010
Decreased clearance of CNS beta-amyloid in Alzheimer's diseaseKwasi G Mawuenyega, Wendy Sigurdson, Vitaliy Ovod, et al.
Plos One|March 21, 2014
Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous systemJustyna A Dobrowolska, Tom Kasten, Yafei Huang, et al.
Archives of Neurology|September 14, 2011
Effects of age and amyloid deposition on Aβ dynamics in the human central nervous systemYafei Huang, Rachel Potter, Wendy Sigurdson, et al.
Archives of Neurology|December 12, 2012
β-amyloid dynamics in human plasmaYafei Huang, Rachel Potter, Wendy Sigurdson, et al.
Alzheimer'S Research & Therapy|March 8, 2016
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humansMikko Hölttä, Robert A Dean, Eric Siemers, et al.
Annals of Neurology|June 5, 2015
Age and amyloid effects on human central nervous system amyloid-beta kineticsBruce W Patterson, Donald L Elbert, Kwasi G Mawuenyega, et al.
Science Translational Medicine|June 14, 2013
Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriersRachel Potter, Bruce W Patterson, Donald L Elbert, et al.
Alzheimer'S Research & Therapy|July 27, 2018
Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer NetworkCeleste M Karch, Damián Hernández, Jen-Chyong Wang, et al.
Nature Medicine|February 10, 2025
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementiaJorge J Llibre-Guerra, M Victoria Fernandez, Nelly Joseph-Mathurin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Analytical Biochemistry|May 30, 2013
Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kineticsKwasi G Mawuenyega, Tom Kasten, Wendy Sigurdson, et al.
Science (New York, N.Y.)|December 15, 2010
Decreased clearance of CNS beta-amyloid in Alzheimer's diseaseKwasi G Mawuenyega, Wendy Sigurdson, Vitaliy Ovod, et al.
Plos One|March 21, 2014
Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous systemJustyna A Dobrowolska, Tom Kasten, Yafei Huang, et al.
Archives of Neurology|September 14, 2011
Effects of age and amyloid deposition on Aβ dynamics in the human central nervous systemYafei Huang, Rachel Potter, Wendy Sigurdson, et al.
Archives of Neurology|December 12, 2012
β-amyloid dynamics in human plasmaYafei Huang, Rachel Potter, Wendy Sigurdson, et al.
Alzheimer'S Research & Therapy|March 8, 2016
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humansMikko Hölttä, Robert A Dean, Eric Siemers, et al.
Annals of Neurology|June 5, 2015
Age and amyloid effects on human central nervous system amyloid-beta kineticsBruce W Patterson, Donald L Elbert, Kwasi G Mawuenyega, et al.
Science Translational Medicine|June 14, 2013
Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriersRachel Potter, Bruce W Patterson, Donald L Elbert, et al.
Alzheimer'S Research & Therapy|July 27, 2018
Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer NetworkCeleste M Karch, Damián Hernández, Jen-Chyong Wang, et al.
Nature Medicine|February 10, 2025
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementiaJorge J Llibre-Guerra, M Victoria Fernandez, Nelly Joseph-Mathurin, et al.
Pageof 1